If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

BHVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.40%

Insider Buying (Last 12 Months): $19,221,533.60

Insider Selling (Last 12 Months): $594,300.00

Biohaven Insider Trading History Chart

Biohaven Share Price & Price History

^$13.40

▲ +0.46 (3.55%)

As of 03/23/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Biohaven Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/31/2022	Vlad Coric	CEO	Buy	25,800	$15.97	$412,026.00	1,543,394
10/28/2022	Vlad Coric	CEO	Buy	41,930	$14.87	$623,499.10	1,517,594
10/25/2022	Gregory H. Bailey	Director	Buy	200,000	$10.50	$2,100,000.00	1,507,971
10/25/2022	Matthew Buten	CFO	Buy	142,857	$10.50	$1,499,998.50	166,653
10/25/2022	Vlad Coric	CEO	Buy	853,380	$10.50	$8,960,490.00	1,475,664
8/19/2022	Gregory H. Bailey	Director	Buy	38,000	$148.04	$5,625,520.00	2,583,658
5/10/2022	George C. Clark	CAO	Sell	4,200	$141.50	$594,300.00	4,065
1/19/2022	George C. Clark	CAO	Sell	9,375	$117.01	$1,096,968.75
12/20/2021	George C. Clark	CAO	Sell	1,915	$123.84	$237,153.60
12/20/2021	Julia P. Gregory	Director	Sell	12,000	$125.00	$1,500,000.00
12/15/2021	Elyse Stock	Insider	Sell	21,919	$105.49	$2,312,235.31
12/10/2021	James Engelhart	CFO	Sell	35,000	$102.55	$3,589,250.00
11/29/2021	Declan Doogan	Director	Sell	24,525	$112.80	$2,766,420.00
11/16/2021	Declan Doogan	Director	Sell	37,740	$116.65	$4,402,371.00
11/10/2021	John W. Childs	Director	Buy	5,000	$122.87	$614,350.00
3/17/2021	John W. Childs	Director	Buy	13,157	$76.00	$999,932.00
3/2/2021	John W. Childs	Director	Buy	10,000	$85.14	$851,400.00	2,532,644
11/23/2020	John W. Childs	Director	Buy	5,000	$89.55	$447,750.00	2,516,938
11/2/2020	William A. Jones, Jr.	Insider	Sell	30,000	$76.22	$2,286,600.00	31,755
10/22/2020	Gregory H. Bailey	Director	Sell	24,566	$79.47	$1,952,260.02	2,559,161
10/19/2020	Gregory H. Bailey	Director	Sell	4,554	$78.98	$359,674.92	2,585,181
10/16/2020	Gregory H. Bailey	Director	Sell	3,748	$78.88	$295,642.24	2,585,181
10/12/2020	Gregory H. Bailey	Director	Sell	6,729	$78.87	$530,716.23	2,588,929
10/8/2020	Kimberly Gentile	SVP	Sell	23,500	$76.34	$1,793,990.00	27,139
9/21/2020	John W. Childs	Director	Buy	3,322	$59.25	$196,828.50	2,511,938
9/11/2020	John W. Childs	Director	Buy	6,678	$59.00	$394,002.00	2,508,616
7/8/2020	Gregory H. Bailey	Director	Sell	50,000	$75.22	$3,761,000.00	2,601,649
7/8/2020	Robert Berman	Insider	Sell	58,404	$75.25	$4,394,901.00	58,745
6/24/2020	Gregory H. Bailey	Director	Sell	3,995	$69.86	$279,090.70	2,737,829
6/23/2020	Robert Berman	Insider	Sell	4,296	$75.05	$322,414.80	4,637
6/22/2020	Gregory H. Bailey	Director	Sell	80,331	$73.24	$5,883,442.44	2,973,646
6/19/2020	Gregory H. Bailey	Director	Sell	164,031	$71.22	$11,682,287.82	2,973,646
6/18/2020	Robert Berman	Insider	Sell	61,314	$75.27	$4,615,104.78	36,655
6/17/2020	Kimberly Gentile	SVP	Sell	24,000	$70.20	$1,684,800.00	27,639
6/15/2020	Declan Doogan	Director	Sell	80,000	$66.73	$5,338,400.00	373,913
6/12/2020	Declan Doogan	Director	Sell	160,000	$66.00	$10,560,000.00	373,913
6/12/2020	Elyse Stock	Insider	Sell	36,966	$66.00	$2,439,756.00	22,560
6/11/2020	James Engelhart	CFO	Sell	73,725	$66.00	$4,865,850.00	15,975
6/10/2020	John Tilton	Insider	Sell	52,000	$67.38	$3,503,760.00	52,770
6/8/2020	Kimberly Gentile	SVP	Sell	600	$70.05	$42,030.00	4,239
4/6/2020	John W. Childs	Director	Sell	150,000	$31.25	$4,687,500.00	2,682,279

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Biohaven (NYSE:BHVN)

98.01% of Biohaven stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Biohaven Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/16/2023	Alliancebernstein L.P.	36,018	$0.50M	0.0%	-88.5%	0.053%
2/16/2023	Chartwell Investment Partners LLC	22,592	$0.31M	0.0%	N/A	0.033%
2/15/2023	Gamco Investors INC. ET AL	11,000	$0.15M	0.0%	-59.8%	0.016%
2/15/2023	Tang Capital Management LLC	140,000	$1.94M	0.3%	-50.0%	0.205%
2/15/2023	Legal & General Group Plc	36,552	$0.51M	0.0%	-57.8%	0.054%
2/15/2023	Morgan Stanley	284,368	$3.95M	0.0%	-51.2%	0.417%
2/15/2023	Norges Bank	662,813	$9.20M	0.0%	N/A	0.972%
2/15/2023	E Fund Management Co. Ltd.	18,474	$0.26M	0.0%	+484.6%	0.027%
2/15/2023	Eversept Partners LP	185,595	$2.58M	0.2%	-70.9%	0.272%
2/15/2023	Fred Alger Management LLC	201,288	$2.79M	0.0%	N/A	0.295%
2/15/2023	Armistice Capital LLC	2,724,000	$37.81M	0.7%	+90.2%	3.996%
2/15/2023	Avidity Partners Management LP	1,492,000	$20.71M	0.4%	N/A	2.189%
2/15/2023	Bardin Hill Management Partners LP	25,093	$0.35M	0.1%	-88.9%	0.037%
2/15/2023	Boothbay Fund Management LLC	150,917	$2.10M	0.0%	+1,480.0%	0.221%
2/14/2023	Point72 Asset Management L.P.	1,231,409	$17.09M	0.1%	+224.1%	1.807%
2/14/2023	RP Management LLC	2,936,507	$40.76M	48.0%	+164.3%	4.308%
2/14/2023	Alyeska Investment Group L.P.	200,000	$2.78M	0.0%	N/A	0.293%
2/14/2023	Price T Rowe Associates Inc. MD	1,316,204	$18.27M	0.0%	+269.5%	1.931%
2/14/2023	Putnam Investments LLC	23,538	$0.33M	0.0%	-76.8%	0.035%
2/14/2023	Marshall Wace LLP	2,157,767	$29.95M	0.1%	+65.1%	3.166%
2/14/2023	Driehaus Capital Management LLC	870,050	$12.08M	0.2%	+1,611.7%	1.276%
2/14/2023	Soros Fund Management LLC	202,903	$2.82M	0.0%	-91.1%	0.298%
2/13/2023	Advisors Asset Management Inc.	1,997	$28K	0.0%	-75.4%	0.003%
2/13/2023	Charles Schwab Investment Management Inc.	510,920	$7.09M	0.0%	+4.5%	0.750%
2/13/2023	Deutsche Bank AG	41,356	$0.57M	0.0%	-22.5%	0.061%
2/13/2023	Brown Advisory Inc.	373,972	$5.19M	0.0%	-50.3%	0.549%
2/13/2023	Public Employees Retirement Association of Colorado	3,634	$50K	0.0%	-50.0%	0.005%
2/13/2023	Gabelli Funds LLC	26,000	$0.36M	0.0%	-51.4%	0.038%
2/13/2023	Gamco Investors INC. ET AL	11,000	$0.15M	0.0%	-59.8%	0.016%
2/13/2023	Dark Forest Capital Management LP	4,334	$60K	0.0%	-49.2%	0.006%
2/13/2023	Wells Fargo & Company MN	3,063	$43K	0.0%	-44.8%	0.004%
2/13/2023	Barclays PLC	196,068	$2.72M	0.0%	-10.1%	0.288%
2/13/2023	The Manufacturers Life Insurance Company	84,526	$1.20M	0.0%	+248.7%	0.124%
2/13/2023	Geode Capital Management LLC	1,120,604	$15.55M	0.0%	+2.1%	1.644%
2/13/2023	American Century Companies Inc.	416,092	$5.78M	0.0%	+44.6%	0.610%
2/13/2023	JPMorgan Chase & Co.	685,391	$9.51M	0.0%	-66.4%	1.006%
2/13/2023	Artal Group S.A.	500,000	$6.94M	0.4%	N/A	0.734%
2/10/2023	Opaleye Management Inc.	540,000	$7.50M	2.6%	N/A	0.792%
2/10/2023	Bank of America Corp DE	390,862	$5.43M	0.0%	-3.0%	0.573%
2/10/2023	Creative Planning	10,601	$0.15M	0.0%	N/A	0.016%
2/10/2023	Tekla Capital Management LLC	35,087	$0.49M	0.0%	-50.0%	0.051%
2/10/2023	Advisor Group Holdings Inc.	8,606	$0.12M	0.0%	+219.8%	0.013%
2/10/2023	Clearbridge Investments LLC	421,299	$5.85M	0.0%	-49.3%	0.618%
2/10/2023	Vanguard Personalized Indexing Management LLC	28,821	$0.40M	0.0%	+361.3%	0.042%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	27,047	$0.38M	0.0%	+2.5%	0.040%
2/9/2023	Dimensional Fund Advisors LP	19,086	$0.27M	0.0%	-57.9%	0.028%
2/9/2023	Principal Financial Group Inc.	12,896	$0.18M	0.0%	-21.4%	0.019%
2/9/2023	Monashee Investment Management LLC	200,000	$2.78M	1.2%	-50.0%	0.293%
2/9/2023	Citigroup Inc.	162,477	$2.26M	0.0%	-67.6%	0.238%
2/8/2023	UBS Group AG	617,952	$8.58M	0.0%	-25.9%	0.907%
2/8/2023	JBF Capital Inc.	13,150	$0.18M	0.0%	+31.5%	0.019%
2/8/2023	California Public Employees Retirement System	97,932	$1.36M	0.0%	-32.3%	0.144%
2/8/2023	Russell Investments Group Ltd.	29,068	$0.40M	0.0%	-50.0%	0.043%
2/7/2023	LPL Financial LLC	25,841	$0.36M	0.0%	N/A	0.038%
2/7/2023	TD Asset Management Inc	64,573	$0.90M	0.0%	N/A	0.095%
2/6/2023	New England Capital Financial Advisors LLC	18,000	$0.33M	0.2%	N/A	0.026%
2/3/2023	Birchview Capital LP	7,365	$0.10M	0.1%	-50.0%	0.011%
2/2/2023	Nisa Investment Advisors LLC	87,562	$1.22M	0.0%	+2,540.6%	0.128%
2/1/2023	Bank of Montreal Can	16,611	$0.23M	0.0%	-69.9%	0.024%
1/30/2023	New York State Common Retirement Fund	46,242	$0.64M	0.0%	+2.6%	0.068%
1/27/2023	Exchange Traded Concepts LLC	8,926	$0.12M	0.0%	N/A	0.013%
1/26/2023	Inspire Investing LLC	42,550	$0.59M	0.1%	+300.2%	0.062%
1/26/2023	Strs Ohio	13,300	$0.18M	0.0%	+22.0%	0.020%
1/25/2023	ARS Investment Partners LLC	564,239	$7.83M	1.0%	+1,129.5%	0.828%
1/24/2023	Sigma Planning Corp	19,148	$0.27M	0.0%	+588.5%	0.028%
1/19/2023	Canton Hathaway LLC	17,600	$0.24M	0.1%	+340.0%	0.026%
1/18/2023	Exchange Traded Concepts LLC	8,926	$0.12M	0.0%	N/A	0.013%
12/8/2022	Bank of New York Mellon Corp	1,000,497	$151.24M	0.0%	-1.5%	1.468%
12/6/2022	Weiss Asset Management LP	247,581	$37.43M	0.9%	+116.0%	0.363%
12/5/2022	Weiss Asset Management LP	247,581	$37.43M	0.8%	+116.0%	0.363%
11/21/2022	California State Teachers Retirement System	76,928	$11.63M	0.0%	-1.1%	0.113%
11/17/2022	Westchester Capital Management LLC	945,499	$142.93M	2.9%	+289.4%	1.387%
11/16/2022	Balyasny Asset Management LLC	610,571	$92.30M	0.3%	+82.9%	0.896%
11/16/2022	BNP Paribas Arbitrage SNC	36,295	$5.49M	0.0%	+161.4%	0.053%
11/15/2022	Alliancebernstein L.P.	314,412	$47.53M	0.0%	-10.6%	0.461%
11/15/2022	State Street Corp	2,233,366	$266.64M	0.0%	+28.0%	3.277%
11/15/2022	Algert Global LLC	19,192	$2.90M	0.2%	+38.6%	0.028%
11/15/2022	Symmetry Investments LP	2,730	$0.41M	0.1%	N/A	0.004%
11/15/2022	TIG Advisors LLC	1,154,153	$152.38M	5.5%	+12.1%	1.693%
11/15/2022	Twin Securities Inc.	82,499	$8.49M	4.0%	+175.0%	0.121%
11/15/2022	UBS Asset Management Americas Inc.	63,992	$9.67M	0.0%	-81.1%	0.094%
11/15/2022	Utah Retirement Systems	7,900	$1.19M	0.0%	N/A	0.012%
11/15/2022	Vanguard Group Inc.	1,439,571	$217.62M	0.0%	+0.5%	2.112%
11/15/2022	P Schoenfeld Asset Management LP	328,000	$49.58M	2.8%	N/A	0.481%
11/15/2022	Prelude Capital Management LLC	35,549	$5.37M	0.2%	-30.8%	0.052%
11/15/2022	Price T Rowe Associates Inc. MD	356,257	$53.86M	0.0%	-31.7%	0.523%
11/15/2022	Putnam Investments LLC	101,368	$15.32M	0.0%	-7.4%	0.149%
11/15/2022	PenderFund Capital Management Ltd.	1,530	$0.32M	0.1%	N/A	0.002%
11/15/2022	Marshall Wace LLP	1,306,756	$11.04M	0.0%	-32.2%	1.917%
11/15/2022	Eventide Asset Management LLC	495,432	$74.89M	1.5%	-56.1%	0.727%
11/15/2022	Engineers Gate Manager LP	3,556	$0.54M	0.0%	+110.9%	0.005%
11/15/2022	Ethic Inc.	1,916	$0.29M	0.0%	N/A	0.003%
11/15/2022	Farallon Capital Management LLC	2,182,820	$295.93M	1.8%	+12.1%	3.202%
11/15/2022	First Trust Capital Management L.P.	288,887	$43.67M	2.1%	+7,008.4%	0.424%
11/15/2022	Bank of New York Mellon Corp	1,000,497	$151.24M	0.0%	-1.5%	1.468%
11/15/2022	BlackRock Inc.	4,949,917	$748.28M	0.0%	-2.4%	7.262%
11/14/2022	GABELLI & Co INVESTMENT ADVISERS INC.	71,362	$10.79M	1.4%	-28.6%	0.105%
11/14/2022	Gamco Investors INC. ET AL	27,350	$4.13M	0.0%	+35.3%	0.040%
11/14/2022	Gabelli Funds LLC	53,483	$8.09M	0.1%	-74.6%	0.078%
11/14/2022	Armistice Capital LLC	1,432,000	$9.02M	0.2%	N/A	2.101%

Data available starting January 2016

Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. The company's pipeline products include BHV-7000, a potassium channel activator for the treatment of focal epilepsy; Troriluzole, a tripeptide prodrug that is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500, a low-trapping glutamate N-methyl-D-aspartate receptor antagonist for neuropathic pain; and Verdiperstat, an irreversible myeloperoxidase enzyme inhibitor for the treatment of neurodegenerative diseases. It also offers Taldefgrobep Alfa, an anti-myostatin adnectin, which is in Phase 3 clinical trial to treat spinal muscle atrophy; and BHV-1100 that is in Phase 1a/1b clinical trial for multiple myeloma patients. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in Sept 2022. The company was incorporated in 2022 and is headquartered in New Haven, Connecticut. Biohaven Ltd. is a subsidiary of Biohaven Pharmaceutical Holding Company Ltd.

Today's Range

Now: $13.40

$12.78

$13.55

50 Day Range

MA: $16.34

$12.94

$19.20

52 Week Range

Now: $13.40

$5.54

$20.57

Volume

753,498 shs

Average Volume

1,103,818 shs

Market Capitalization

$913.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Who are the company insiders with the largest holdings of Biohaven?: Biohaven's top insider shareholders include:
Gregory Bailey (Director)
Vlad Coric (CEO)
Matthew Buten (CFO)
George C Clark (CAO)
Declan Doogan (Director)
Elyse Stock (Insider)
James Engelhart (CFO)
John W Childs (Director)
Julia P Gregory (Director)
Learn More about top insider investors at Biohaven.
Who are the major institutional investors of Biohaven?: Biohaven's top institutional shareholders include:
RP Management LLC — 4.31%
Armistice Capital LLC — 4.00%
Marshall Wace LLP — 3.17%
Avidity Partners Management LP — 2.19%
Price T Rowe Associates Inc. MD — 1.93%
Point72 Asset Management L.P. — 1.81%
Learn More about top institutional investors of Biohaven stock.
Which major investors are selling Biohaven stock?: During the last quarter, BHVN stock was sold by these institutional investors:
Soros Fund Management LLC
JPMorgan Chase & Co.
Eversept Partners LP
Millennium Management LLC
Clearbridge Investments LLC
Brown Advisory Inc.
Citigroup Inc.
Morgan Stanley
Which major investors are buying Biohaven stock?: During the last quarter, BHVN stock was bought by institutional investors including:
RP Management LLC
Avidity Partners Management LP
Armistice Capital LLC
Price T Rowe Associates Inc. MD
Point72 Asset Management L.P.
Marshall Wace LLP
Driehaus Capital Management LLC
Norges Bank
Within the previous year, these company insiders have bought Biohaven stock:
Gregory Bailey (Director)
Vlad Coric (CEO)
Matthew Buten (CFO)
George C Clark (CAO)
Learn More investors buying Biohaven stock.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

BHVN Insider Trading

Biohaven Insider Trading History Chart

Biohaven Share Price & Price History

Biohaven Insider Trading History

SEC Filings (Institutional Ownership Changes) for Biohaven (NYSE:BHVN)

Institutional Buying and Selling by Quarter

Biohaven Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Biohaven?

Who are the major institutional investors of Biohaven?

Which major investors are selling Biohaven stock?

Which major investors are buying Biohaven stock?